Granted Patent
B2
US 8,618,174 · App. 13/235,787 · Granted Dec 31, 2013
Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Inventors:
William Hewitt (Pottstown, PA); Daniel L Vasella (Basel, CH); Randy L Webb (Flemington, NJ)
Assignee:
Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.
Claims (4)
1. A pharmaceutical composition comprising the renin inhibitor of formula (I)
as a hemi-fumarate, hydrochlorothiazide, amlodipine or a pharmaceutically acceptable salt thereof, and a carrier.
2. The composition according to claim 1 for the treatment of hypertension.
3. The composition according to claim 1 for simultaneous, separate or sequential use.
Assignments (3)
CHANGE OF ADDRESS
Recorded Mar 21, 2017
From: NODEN PHARMA DAC
To: NODEN PHARMA DAC
Reel/Frame 042084/0980 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 039481 FRAME 0233. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Recorded Aug 29, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 040003/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 26, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 039481/0233 →
Priority Claims (1)
GB 0028151.9
· Nov 17, 2000
· national
Continuity (2)
Division
10416039